Search Results - Paul Brinkman

Reducing social diabetes distress with a conversational agent support system: a three-week technology feasibility evaluation by Merijn Bruijnes, Merijn Bruijnes, Mitchell Kesteloo, Willem-Paul Brinkman

Connect to this object online.

Using a conversational agent for thought recording as a cognitive therapy task: Feasibility, content, and feedback by Franziska Burger, Mark A. Neerincx, Mark A. Neerincx, Willem-Paul Brinkman

Connect to this object online.

Precision Medicine in Neonates: Future Perspectives for the Lung by Wes Onland, Jeroen Hutten, Martijn Miedema, Lieuwe D. Bos, Paul Brinkman, Anke H. Maitland-van der Zee, Anton H. van Kaam

Connect to this object online.

Feasibility of generating structured motivational messages for tailored physical activity coaching by Ramya P. Ghantasala, Nele Albers, Kristell M. Penfornis, Kristell M. Penfornis, Milon H. M. van Vliet, Milon H. M. van Vliet, Willem-Paul Brinkman

Connect to this object online.

Volatile organic compound detection of Buruli ulcer disease: Headspace analysis of Mycobacterium ulcerans and used gauzes of Buruli-compatible ulcers. by Stan F J Chudy, Delphin M Phanzu, Arend H J Kolk, Ghislain E Sopoh, Yves T Barogui, Oren Tzfadia, Miriam Eddyani, Krista Fissette, Bouke C de Jong, Paul Brinkman

Connect to this object online.

A randomized controlled trial to pilot the efficacy of a computer-based intervention with elements of virtual reality and limited therapist assistance for the treatment of post-tra... by Marieke van Meggelen, Marieke van Meggelen, Nexhmedin Morina, Colin van der Heiden, Colin van der Heiden, Willem-Paul Brinkman, Iris E. Yocarini, Myrthe L. Tielman, Jan Rodenburg, Elisa van Ee, Elisa van Ee, Kevin van Schie, Kevin van Schie, Marijke E. Broekman, Ingmar H. A. Franken

Connect to this object online.

Real‐life efficacy and safety of elexacaftor/tezacaftor/ivacaftor on severe cystic fibrosis lung disease patients by Renate Kos, Anne H. Neerincx, Dominic W. Fenn, Paul Brinkman, Rianne Lub, Steffie E. M. Vonk, Jolt Roukema, Monique H. Reijers, Suzanne W. J. Terheggen‐Lagro, Josje Altenburg, Christof J. Majoor, Lieuwe D. Bos, Eric G. Haarman, Anke H. Maitland‐van der Zee, the Amsterdam Mucociliary Clearance Disease (AMCD)

Connect to this object online.

Integrating treatment cost reduction strategies and biomarker research to reduce costs and personalize expensive treatments: an example of a self-funding trial in non-small cell lu... by Alessandra I. G. Buma, Berber Piet, Rob ter Heine, Michel M. van den Heuvel, Paul Brinkman, Daan van den Broek, Sjaak Burgers, Francesco Ciompi, Simona M. Cristescu, Bram van Ginneken, Katrien Grünberg, Lizza Hendriks, Jeroen Hiltermann, Firdaus Mohamed Housein, Alwin Huitema, Jakko van Inge, Colin Jacobs, Hans Koenen, Marjolijn Ligtenberg, Anke H. Maitland-van der Zee, Vincent van der Noort, Mathias Prokop, Valesca Rètel, Heinrich Roder, Huub van Rossum, Ruben Smeets, Thomas Würdinger

Connect to this object online.